Phenotypeca are actively seeking partners in academia, not for profit and commercial groups that have projects in the biopharmaceutical product areas of Vaccines, Diagnostics and Recombinant Therapeutics (no matter how difficult they may be to express).
You will benefit from expertise and a robust second generation yeast expression platform that can be optimised to produce your protein of interest. We can also do comparative studies (For example vs E. coli) to give you more information and to aid the selection of an appropriate expression platform for your product.
If you would like investor information, or a discussion about investing in Phenotypeca please contact us at: email@example.com
If you have any questions, or would like to find out more about our unique processes, please get in touch.